Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- HGP2304-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HGP2304-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HIP0612Phase 31 trial
Hanmi Pharmaceutical Company Limited · Gastric Ulcer
- HIP2602Phase 31 trial
Hanmi Pharmaceutical Company Limited · Erectile Dysfunction
- HLX04-OPhase 31 trial
Shanghai Henlius Biotech · Age Related Macular Degeneration
- HLX11Phase 31 trial
Shanghai Henlius Biotech · Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer
- HLX13Phase 31 trial
Shanghai Henlius Biotech · Hepatocellular Carcinoma (HCC)
- HLX15Phase 31 trial
Shanghai Henlius Biotech · Newly Diagnosed Multiple Myeloma
- HLX17Phase 31 trial
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer
- HMI-115Phase 31 trial
Hope Medicine (Nanjing) Co., Ltd · Endometriosis
- HMPL-760Phase 31 trial
Hutchmed · Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- HPP2002-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HPP2003-3Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HPP2201Phase 31 trial
Hanmi Pharmaceutical Company Limited · Gastric Ulcer
- HPP2202Phase 31 trial
Hanmi Pharmaceutical Company Limited · Gastric Ulcer
- HPP2602-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Erectile Dysfunction
- HPP2602-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Erectile Dysfunction
- HPP737Phase 31 trial
Newsoara Biopharma Co., Ltd. · Psoriasis
- HR-1703Phase 31 trial
Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma With Eosinophilic Phenotype
- HR070803Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Colorectal Cancer
- HR091506Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Gout With Hyperuricemia in Adults
- HR20013Phase 31 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
- HRS-4357Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
- HRS8179Phase 31 trial
Beijing Suncadia Pharmaceuticals Co., Ltd · Severe Cerebral Edema Following Large Hemispheric Infarction
- HS-10370Phase 31 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Carcinoma, Non-Small-Cell Lung
- HS-10504Phase 31 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced or Metastatic NSCLC
- HS-20117PM1080Phase 31 trial
Hansoh BioMedical R&D Company · Non-Squamous Non-Small Cell Lung Cancer
- HS627Phase 31 trial
BioRay Pharmaceutical Co., Ltd. · Breast Cancer
- HSK16149Phase 31 trial
Haisco Pharmaceutical Group Co., Ltd. · Central Neuropathic Pain
- HSK3486Phase 31 trial
Haisco Pharmaceutical Group Co., Ltd. · General Anesthetic
- HU-045Phase 31 trial
Huons Biopharma · Glabellar Lines
- hu1418K322APhase 31 trial
Renaissance Pharma Ltd. · High-Risk Neuroblastoma
- Huperzine A Controlled-ReleasePhase 31 trial
Wanbangde Pharmaceutical Group Co., LTD · Alzheimer Dementia
- HX22Phase 31 trial
Shanghai Henlius Biotech · HER2 + Breast Cancer
- I004Phase 31 trial
Amphastar Pharmaceuticals, Inc. · Pharmacokinetics, Pharmacodynamics, Insulin Aspart
- IAE0972Phase 31 trial
SUNHO(China)BioPharmaceutical CO., Ltd. · NPC, HNSCC, Recurrence
- IAH0968Phase 31 trial
SUNHO(China)BioPharmaceutical CO., Ltd. · Stomach Neoplasms, Solid Tumor
- IBI3027Phase 31 trial
Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis
- IBI306Phase 31 trial
Innovent Biologics (Suzhou) Co. Ltd. · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
- IBP-9414Phase 31 trial
Infant Bacterial Therapeutics · Necrotizing Enterocolitis
- iCM012Phase 31 trial
iCoat Medical AB · Ischemia-reperfusion Injury, Kidney Transplant; Complications
- IcotinibPhase 31 trial
Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy
- IDRX-42velzatinib - subject to USAN approvalPhase 31 trial
GSK · Gastrointestinal Neoplasms
- IgPro20Immune Globulin 20% LiquidPhase 31 trial
CSL Behring · Secondary Immune Deficiency
- IHL-42XInvestigational Product - IHL-42X, Optimal DosePhase 31 trial
Incannex Healthcare Ltd · Obstructive Sleep Apnea
- Ilaprazolethe brand name, NoltecPhase 31 trial
Il-Yang Pharm. Co., Ltd. · Peptic Ulcer
- IMP4927Phase 31 trial
Impact Therapeutics, Inc. · Ovarian Cancer
- INBRX-106OrdastobartPhase 31 trial
Inhibrx Biosciences, Inc · Head and Neck Squamous Cell Carcinoma (HNSCC), HPV Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)
- INCA033989Phase 31 trial
Incyte · Essential Thrombocythemia
- INCB161734Phase 31 trial
Incyte · Solid Tumors
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.